tetramethylrhodamine isothiocyanate and Breast Cancer

tetramethylrhodamine isothiocyanate has been researched along with Breast Cancer in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Da Poian, AT; de Freitas, MS; Holandino, C; Marinho-Carvalho, MM; Meira, DD; Sola-Penna, M; Teixeira, CA; Veiga, VF	1

Other Studies

1 other study(ies) available for tetramethylrhodamine isothiocyanate and Breast Cancer

Article	Year
Clotrimazole decreases human breast cancer cells viability through alterations in cytoskeleton-associated glycolytic enzymes. Molecular genetics and metabolism, 2005, Volume: 84, Issue:4 Topics: Actins; Breast Neoplasms; Carcinoma, Ductal, Breast; Cell Line, Tumor; Cell Survival; Clotrimazole; Cytoskeleton; Dose-Response Relationship, Drug; Female; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Fructose-Bisphosphate Aldolase; Glucose; Growth Inhibitors; Humans; Lactic Acid; Phalloidine; Phosphofructokinase-1; Rhodamines; Streptavidin	2005

Article

Year

Clotrimazole decreases human breast cancer cells viability through alterations in cytoskeleton-associated glycolytic enzymes.

Molecular genetics and metabolism, 2005, Volume: 84, Issue:4

Topics: Actins; Breast Neoplasms; Carcinoma, Ductal, Breast; Cell Line, Tumor; Cell Survival; Clotrimazole; Cytoskeleton; Dose-Response Relationship, Drug; Female; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Fructose-Bisphosphate Aldolase; Glucose; Growth Inhibitors; Humans; Lactic Acid; Phalloidine; Phosphofructokinase-1; Rhodamines; Streptavidin

2005